financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Hold Opinion On Shares Of United Parcel Service
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Hold Opinion On Shares Of United Parcel Service
Apr 23, 2024 9:23 PM

12:10 AM EDT, 04/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target price of $149, raised $1, reflects a 15x multiple of projected '25 EPS, in line with UPS's historical forward average. We cut our '24 EPS estimate by $0.14 to $8.22, but raise '25's by $0.07 to $9.96. Q1 EPS of $1.43, vs. $2.20, beat consensus by $0.08. In UPS's U.S. Domestic segment, average daily volumes fell 3.2% Y/Y, and revenues fell 5.0%, indicative in our view of ongoing (albeit modest) pricing pressure. We see a similar situation in the International segment, where average daily volumes dropped 5.8% Y/Y and revenues fell 6.3%. UPS maintains its '24 revenue guidance of a range of $92.0B-$94.5B, which would suggest revenue growth in '24 of 1%-4%, likely with an acceleration in 2H '24. We think cost efforts will be key to UPS achieving higher earnings power, but likely bearing fruit in '25, after a down year in '24. We think a near-term volume recovery remains a bit elusive and is dependent on a broader macro recovery.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
May 8, 2024
Treating America's obesity epidemic is turning into big business. Two pharmaceutical companies, Eli Lilly ( LLY ) and Novo Nordisk ( NVO ) , are leading the weight-loss revolution with a new class of drugs known as GLP-1 agonists. Surging revenue and growing excitement has led some analysts to compare the success of GLP-1 drugs in the health and wellness...
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Trade Desk, Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Trade Desk, Inc.
May 8, 2024
12:45 AM EDT, 05/09/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target at $100, on a P/E of 53.5x our '25 view, above peers but within its 10-year historical forward average. We keep our above consensus '24...
Research Alert: CFRA Lowers Opinion On Shares Of United Parks & Resorts Inc. To Hold From Buy
Research Alert: CFRA Lowers Opinion On Shares Of United Parks & Resorts Inc. To Hold From Buy
May 8, 2024
02:35 AM EDT, 05/09/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We trim our 12-month target to $56 from $61, on 2024 EV/EBITDA of 7.3x, near the low-end of PRKS's long-term trading range of 7x-12x. We lift our 2024 EPS to...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Arm Holdings Plc
Research Alert: CFRA Maintains Hold Opinion On Shares Of Arm Holdings Plc
May 9, 2024
08:05 AM EDT, 05/09/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our 12-month target to $120 from $140, on a lower revised peer-premium P/E of 64.8x our CY 25 EPS estimate, warranted given our view of growth prospects. We...
Copyright 2023-2026 - www.financetom.com All Rights Reserved